| ★ 31.10.2026 15:09 UTC | Regeneron: 3 Key Takeaways for Long-Term Investors | Motley Fool |
| ★ 31.10.2026 14:30 UTC | Regeneron Stock Just Hit a 2-Year High. Here's Why. | Barchart |
| ★ 31.10.2026 09:39 UTC | Regeneron (REGN) stock trades up, here is why | StockStory |
| ★ 30.10.2026 23:12 UTC | Sanofi SA (SNY) (Q3 2026) Earnings Call Highlights: Dupixent Tops EUR5 Billion Again as ... | GuruFocus.com |
| ★ 30.10.2026 22:17 UTC | EssilorLuxottica Stock And Eurozone Healthcare Giants Worth Watching Now | Simply Wall St. |
| ★ 30.10.2026 20:36 UTC | Regeneron Bolts 13% Higher, Breaking Out To A Two-Year High On Dupixent Dominance | Investor's Business Daily |
| ★ 30.10.2026 19:07 UTC | Sanofi Jumps 6% as New CEO Opens Door to Bigger Deals | GuruFocus.com |
| ★ 30.10.2026 17:11 UTC | Alnylam Faces Near-Term Risk on Amvuttra, Oppenheimer Says | MT Newswires |
| ★ 30.10.2026 16:15 UTC | What Regeneron Pharmaceuticals (REGN) Said on Its Q3 Earnings Call | MarketBeat |
| ★ 30.10.2026 12:30 UTC | REGN Stock Hits 2-Year Highs Pre-Market: CFO Says Regeneron Is Positioned To Deliver One Of ‘Strongest Years Ever’ After Q3 Earnings Beat | Stocktwits |
| ★ 30.10.2026 11:13 UTC | Regeneron Q3 revenue tops estimates on Sanofi Dupixent profit; shares rise 4% ▲ Earnings beat | Investing.com |
| ★ 30.10.2026 10:41 UTC | Sanofi CEO Sets Sights on Deals to Drive Turnaround | The Wall Street Journal |
| ★ 30.10.2026 10:30 UTC | Regeneron Reports Third Quarter 2026 Financial and Operating Results | GlobeNewswire |
| ★ 30.10.2026 07:29 UTC | Sanofi Fiscal Q3 Adjusted Earnings, Revenue Rise; 2026 Outlook Raised | MT Newswires |
| ★ 30.10.2026 07:22 UTC | Sanofi Q3 earnings blow past expectations on Dupixent strength; hikes FY guidance | Investing.com |
| ★ 30.10.2026 06:30 UTC | Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded ▲ Upgrade | GlobeNewswire |
| ★ 29.10.2026 14:36 UTC | Novavax Earns $125 Million Milestone Payment From Sanofi's Phase 3 Vaccine Trial in Europe | MT Newswires |
| ★ 29.10.2026 13:15 UTC | Novavax Earns $125 Million Milestone as Sanofi Launches Phase 3 Influenza-COVID-19 Combination Vaccine Trial in Europe | PR Newswire |
| 30.10.2026 19:54 UTC | Sector Update: Healthcare Stocks Rise Late Afternoon | MT Newswires |
| 30.10.2026 17:50 UTC | Sector Update: Healthcare Stocks Rise Friday Afternoon | MT Newswires |
| 30.10.2026 16:55 UTC | Regeneron Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary | Moby |
| 30.10.2026 16:15 UTC | Sanofi Q3 Earnings Call Highlights | MarketBeat |
| 30.10.2026 15:23 UTC | European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading | MT Newswires |
| 30.10.2026 14:45 UTC | Regeneron Soars 12% on Dupixent-Fueled Q3 Beat: “One of Our Strongest Years Ever” | TIKR |
| 30.10.2026 13:15 UTC | Sector Update: Healthcare Stocks Edge Higher Premarket Friday | MT Newswires |
| 30.10.2026 13:05 UTC | Sanofi Q3 Earnings & Sales Beat, 2026 View Up, Shares Rise | Zacks |
| 29.10.2026 21:10 UTC | Alnylam Pharmaceuticals Inc (ALNY) (Q3 2026) Earnings Call Highlights: TTR Franchise Surges 59% ... | GuruFocus.com |
| 29.10.2026 19:48 UTC | Sector Update: Healthcare Stocks Gain Late Afternoon | MT Newswires |
| 29.10.2026 18:07 UTC | Sector Update: Healthcare Stocks Gain Thursday Afternoon | MT Newswires |
| 29.10.2026 13:22 UTC | Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards? | Zacks |